Insider · CIK 0001663298
Charles Olson V
Files at EDSA (Edesa Biotech, Inc.). First filing -, latest -.
In brief
Charles Olson V files SEC Form 4 as director at EDSA (Edesa Biotech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles Olson V has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +19,000 | $0.00 | $0 | 30,000 | May 29, 2026 |
| May 29, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +11,000 | $0.00 | $0 | 11,000 | Jun 2, 2025 |
Questions about Charles Olson V
Answered from the filings on this page, as of the latest one.
Is Charles Olson V buying or selling?
Charles Olson V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles Olson V's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles Olson V has 0.
Where does Charles Olson V file Form 4?
Charles Olson V has filed Form 4 at EDSA (Edesa Biotech, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.